期刊文献+

不同病理分级儿童脑胶质瘤MR灌注成像 被引量:3

Glioma grading in children brain:using MR PWI
下载PDF
导出
摘要 目的:采用磁共振灌注成像(MR PWI)探讨儿童不同级别脑胶质瘤的血流灌注特点及其临床诊断价值。方法:35例脑胶质瘤均经手术病理证实,其中Ⅰ~Ⅱ级胶质瘤(低级别胶质瘤组)28例,Ⅲ级胶质瘤(高级别胶质瘤组)7例,计算病灶内异常高灌注中心区(a区)、异常低灌注中心区(b区)、负性增强积分(NEI)伪彩图与T1WI增强图上不匹配区(c区)的相对NEI值(rNEI)及NEI伪彩图与T1WI增强图像上病变面积的比值(N/C),分析rNEI及N/C与肿瘤病理学分级的相关性。结果:高级别胶质瘤组中a区和c区的rNEI分别为8.39±1.91和5.43±0.52,均大于低级别胶质瘤组(分别为5.10±2.05和4.05±0.66),差异均具有极显著性意义(P<0.01)。高级别及低级别胶质瘤组NEI伪彩图上异常灌注区面积均大于T1WI增强图像上的异常强化区,N/C分别为1.06±0.11和1.45±0.09,差异具有极显著性意义(P<0.01)。结论:采用正确的研究方法MR PWI能有效分析儿童脑胶质瘤的血流灌注情况,对儿童脑胶质瘤的浸润范围的界定及术前分级均能有效判断。 Objective:To study the perfusion characteristics and clinical diagnostic value of the magnetic resonance perfusion weighted imaging(MR PWI) for grading of glioma in children brain.Methods:GE 1.5T HDx Echospeed Plus MRI scanner were used and double dosage(0.2mmol/kg) Gd-DTPA was given.Children(n=35) with brain glioma including 28 cases grade I-II(group A) and 7 cases grade Ⅲ(group B) underwent MR PWI with the injection rate ranged from 2~4ml/s,and all cases were confirmed by pathology.After MR PWI scanning,negative enhancement integral(NEI) maps were obtained.NEI values and Relative NEI(rNEI) were studied by NEI maps.The study indexes included the rNEI of maximum hyper perfusion center(ROI-a),minimum hypo perfusion center(ROI-b),mismatch region of NEI maps and contrast-enhanced MR T1WI(ROI-c),the ratio of focus area in NEI maps and contrast-enhanced MR T1WI(N/C ratio) was studied too.All the study indexes of MR PWI were correlated with pathology.Results:The rNEI of ROI-a and ROI-c in group B was greater than that in group A(P0.01).The abnormal perfusion areas of NEI maps were bigger than the abnormal enhanced areas of T1WI in the two groups.The N/C ratio was 1.06±0.11 in group A and 1.45±0.09 in group B,and there were significant statistical differences in the two groups(P0.01).Conclusion:MR PWI is helpful to the grading and extent definition of glioma in children brain if appropriate methods are adopted.
出处 《放射学实践》 2012年第3期346-349,共4页 Radiologic Practice
基金 广东省科技计划项目(2008B060600045)
关键词 儿童 脑肿瘤 胶质瘤 磁共振成像 灌注成像 Children Brain neoplasms Glioma Magnetic resonance imaging Perfusion imaging
  • 相关文献

参考文献12

  • 1Rizzo L,Crasto SG,Moruno PG,et al.Role of diffusion-and per-fusion-weighted MR imaging for brain tumour characterisation[J].Radiol Med,2009,114(4):645-659.
  • 2Provenzale JM,York G,Moya MG,et al.Correlation of relativepermeability and relative cerebral blood volume in high-grade cer-ebral neoplasms[J].AJR,2006,187(4):1036-1042.
  • 3Price SJ.Advances in imaging low-grade gliomas[J].Adv TechStand Neurosurg,2010,35(1):1-34.
  • 4Lbel U,Sedlacik J,Reddick WE,et al.Quantitative diffusion-weighted and dynamic susceptibility-weighted contrast-enhancedperfusion MR imaging analysis of T2hypointense lesion compo-nents in pediatric diffuse intrinsic pontine glioma[J].AJNR,2011,32(2):315-322.
  • 5Rao P.Role of MRI in paediatric neurooncology[J].Eur J Radiol,2008,68(2):259-270.
  • 6Cha S.Perfusion MR imaging:basic principles and clinical applica-tions[J].Magn Reson Imaging Clin N Am,2003,11(3):403-413.
  • 7Petrella JR,Provenzale JM.MR perfusion imaging of the brain:techniques and applications[J].AJR,2000,175():207-219.
  • 8郭岳霖,张远芳,饶海冰,郑文斌,刘国瑞.儿童脑部磁共振灌注成像技术的初步研究[J].中国临床医学影像杂志,2011,22(7):457-460. 被引量:4
  • 9Kim HS,Kim JH,Kim SH,et al.Posttreatment high-grade glio-ma:usefulness of peak height position with semiquantitative MRperfusion histogram analysis in an entire contrast-enhanced lesionfor predicting volume fraction of recurrence[J].Radiology,2010,256(3):906-915.
  • 10Sawlani RN,Raizer J,Horowitz SW,et al.Glioblastoma:a meth-od for predicting response to antiangiogenic chemotherapy by u-sing MR perfusion imaging——pilot study[J].Radiology,2010,255(2):622-628.

二级参考文献12

  • 1Cha S. Perfusion MR imaging: basic principles and clinical appli- cations [J]. Magn Reson Imaging Clin N Am, 2003, l l (3): 403- 413.
  • 2Petrella JR, Provenzale JM. MR perfusion imaging of the brain: techniques and applications[J]. AJR, 2000, 175: 207-219.
  • 3Senttirk S, Ouz KK, Cila A. Dynamic contrast-enhanced suscep- tibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner[J]. Diagn Interv Radiol, 2009, 15(1): 3- 12.
  • 4Calli C, Kitis O, Yunten N, et al. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors[J]. Eur J Radiol, 2006, 58(3): 394-403.
  • 5Hakyemez B, Erdogan C, Bolca N, et al. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging [J]. J Magn Reson Imaging, 2006, 24(4): 817-824.
  • 6Law M, Young RJ, Babb JS, et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging[J]. Radiology, 2008, 247(2): 490-498.
  • 7Rizzo L, Crasto SG, Moruno PG, et al. Role of diffusion- and perfusion-weighted MR imaging for brain tumor characterization [J]. Radiol Med, 2009, 114(4): 645-659.
  • 8Provenzale JM, York G, Moya MG, et al. Correlation of relative permeability and relative cerebral .blood volume in high-grade cerebral neoplasms[J]. AJR, 2006, 187(4): 1036-1042.
  • 9Yun TJ, Cheon JE, Na DG, et al. Childhood moyamoya disease: quantitative evaluation of perfusion MR imaging correlation with clinical outcome after revascularization surgery[J]. Radiology, 2009, 251(1): 216-223.
  • 10Chen J, Lieht DJ, Smith SE, et al. Arterial spin labeling perfusion MRI in pediatric arterial isehemie stroke: initial experienees[J]. J Magn Reson Imaging, 2009, 29(2): 282-290.

共引文献3

同被引文献25

  • 1Shin JH, Lee HK, Kwun BD, et al. Using relative cerebral blood flow and volume to evaluate the histopathologie grade of cerebral gliomas : preliminary results[J].AJ R, 2002,179 (3) : 783-789.
  • 2Franiel T, Hamm B, Hricak H. Dynamic contrast-enhanced mag- netic resonance imaging and pharmaeokinetic models in prostate cancer[J]. Eur Radiol,2011,21(3) :616-626.
  • 3Kim J H, Lee J M, Park J H, et al. Solid pancreatic lesions : charac terization by using timing bolus dynamic contrast enhanced MR imaging assessment a preliminary study[J]. Radiology, 2013, 266(1) :185-196.
  • 4de Langen AJ, van den Boogaart V, Lubberink M, et al. Monito- ring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic con trast-enhanced MRI[J]. J Nucl Med, 2011,52 ( 1 ) : 48- 55.
  • 5Patankar TF, Haroon HA, Mills SJ, et al. Is volume transfer coef- ficient (Ktrans) related to histologic grade in human gliomas[J]. AJNR,2005,26(10) :2455-2465.
  • 6Mills SJ,Patankar TA, Haroon HA,et al. Do cerebral blood vol- ume and contrast transfer coefficient predict prognosis in human glioma[J]. AJNR,2006,27(4) :853-858.
  • 7Zhang N,Zhang L, Qiu B, et al. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas[J]. J Magn Reson Imaging,2012,36(2) :355-363.
  • 8Yankeelov TE, DeBusk LM, Billheimer DD, el al. Repeatability of a reference region model for analysis of murine DCE-MR1 data at 7T[J]. J Magn Reson Imaging,2006,24(5) :1140-1147.
  • 9Yankeelov TE, Cron GO, Addison CL, et al. Comparison of a reference region model with direct measurement of an A1F in the analysis of DCE-MRI data[J]. Magn Reson Med, 2007,57 (2) : 353-361.
  • 10占传家,朱文珍,王承缘,Louis DN.2007年世界卫生组织对于中枢神经系统肿瘤的分类[J].放射学实践,2008,23(2):122-127. 被引量:78

引证文献3

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部